Yun, Zhao
Powell, Danielle
Mulgirigama, Aruni
Miyazaki, Jun
Article History
First Online: 6 February 2024
Declarations
:
: Participants confirmed their voluntary consent to participate and supplied informed consent in written format. Participants confirmed their understanding that findings from the interview may be published in an anonymised format. This study was non-clinical and was for participant insight purposes only. IRB approval was not required nor sought for participants in China or Japan, per the guidance of the Chinese 2016 Ethics Approval of Biomedical Research That Involves Human Subjects (National Health Commission; available from: ExternalRef removed) and the Japanese 2021 Ethical Guidelines for Human Life Sciences and Medical Research (Ministry of Health, Labour and Welfare, the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Economy, Trade and Industry; available from: ExternalRef removed) and the study did not meet the requirements for needing ethical approval. Respondents were not classified as vulnerable, nor would participation induce undue psychological stress or anxiety.
: Not applicable.
: ZY has no conflict of interest to report. DP and AM are employees of and shareholders in GSK. JM has no conflict of interest to report.